Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Global Health Innovative Technology Fund, Drug Screening Platform. Deadline: 4 July 2025

The Global Health Innovative Technology (GHIT) Fund announces Request for Proposals (RFP) for the screening of compound libraries for the identification of novel compounds for malaria, tuberculosis, Chagas disease and leishmaniasis. The goal is to leverage the active screening programs of established Product Development Partnerships (PDP) and the relevant compound libraries from Japanese companies or academic institutions. 

Possible collaborations should include one of the following three drug development PDPs: Medicines for Malaria Venture (MMV), Drugs for Neglected Diseases initiative (DNDi), and TB Alliance. 

Interested applicants can find detailed information on the RFP on their website. Full applications are due 10:00 am (JST) 4 July 2025 .